HCM Earnings & Financial Statements
HUTCHMED (China) Limited
$13.79
+$0.31(+2.30%)
56
Overall
80
Value
58
Tech
31
Quality
Market Cap
$2.35B
Volume
17.71K
52W Range
$9.77 - $16.33
Target Price
$19.40
HCM earnings and financial statements: HUTCHMED (China) Limited's income statement, balance sheet and cash flow statement, annual and quarterly.
HCM Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $548.51M | $630.20M | $838.00M | $426.41M | $356.13M |
| Cost of revenue | $336.35M | $348.88M | $384.45M | $268.70M | $229.45M |
| Operating income | -$44.93M | -$48.59M | $9.97M | -$407.69M | -$328.32M |
| EBITDA | $537.51M | $60.58M | $67.27M | -$409.77M | -$215.15M |
| Net income | $456.91M | $37.73M | $100.78M | -$360.83M | -$194.65M |
| EPS (diluted) | - | $0.04 | $0.12 | $-6.45 | $-3.75 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $1.75B | $1.27B | $1.28B | $1.03B | $1.37B |
| Total liabilities | $501.83M | $502.34M | $536.39M | $392.57M | $333.15M |
| Shareholders’ equity | $1.24B | $759.93M | $730.54M | $610.37M | $986.89M |
| Cash and equivalents | $71.33M | $153.96M | $283.59M | $178.33M | $104.62M |
| Long-term debt | $76.37M | $70.14M | $51.05M | $23.30M | $7.16M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$64.66M | $497.0K | $219.26M | -$268.60M | -$204.22M |
| Capital expenditure | - | - | - | -$36.66M | -$16.40M |
| Free cash flow | -$88.81M | -$17.44M | $186.65M | -$305.26M | -$220.62M |
| Dividends paid | - | $1.00M | $9.07M | $25.60M | $9.89M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HCM | $13.79 | +2.3% | 17.71K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get HUTCHMED (China) Limited Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW